Editorial Board About Us

Obesity

All articles from this key word are listed below.

Volume 6, Number 2 Review Articles

Examining the Relationship Between Obesity and Prostate Cancer

Management Update

Stephen J Freedland William J Aronson

Obesity Body mass index Dietary fat Insulin-like growth factor Leptin

Volume 6, Supplement 3 Supplement

The Definition, Prevalence, and Risk Factors for Stress Urinary Incontinence

Obesity Stress urinary incontinence Risk factors Pregnancy Urge urinary incontinence Pelvic floor dysfunction

Volume 7, Number 1 Point-Counterpoint

Radical Perineal Prostatectomy: A More Optimal Treatment Approach Than Laproscopic Radical Prostatectomy in Obese Patients

Arnold Melman Albert C Leung

Obesity Laparoscopy Radical perineal prostatectomy

Volume 7, Number 1 Point-Counterpoint

Laproscopic Radical Prostatectomy in Obese Patients: Feasible or Foolhardy?

Prostatic neoplasms Obesity Laparoscopy Prostatectomy

Volume 9, Number 3 Meeting Reviews

Best of the 2007 AUA Annual Meeting

Meeting Review

Michael K Brawer Dean G Assimos Danil V Makarov Ellen Shapiro Alan W Partin Michael B Chancellor J Curtis Nickel Jacob Rajfer Claus G Roehrborn

Highlights from the 2007 Annual Meeting of the American Urological Association May 19-24, 2007 Anaheim, CA [Rev Urol. 2007;9(3):133-154]

Prostate cancer Obesity Benign prostatic hyperplasia Antibiotic prophylaxis Nocturia Lower urinary tract symptoms Botulinum toxin Prostate-specific antigen Biomarkers PCA3 Testosterone Urinary tract infections Urolithiasis Laser ablation Endourology Male voiding dysfunction LHRH antagonists Antimuscarinic agents Circumcision Repeat biopsy Human glandularkallikrein Expectant management CRISP-3 MSP Microvesseldensity Endoglin Survivin Telomeres Interleukin-8 PDE-5 inhibitors Acute urinaryretention 5Alpha-reductase inhibitors Doxazosin Finasteride Transurethral microwave thermotherapy TURP Perioperative blood loss Microbialbiofilms HIV Stem cell injection

Volume 11, Number 2 Meeting Reviews

Best of the 2009 AUA Annual Meeting

Highlights From the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL

F Pouliot Michael K Brawer Naoki Yoshimura Arie S Belldegrun B Shuch Alan W Partin Dean G Assimos Ellen Shapiro Michael B Chancellor Stacy Loeb J Curtis Nickel Claus G Roehrborn

Prostate cancer screening Obesity Benign prostatic hyperplasia Lower urinary tract symptoms Vesicoureteral reflux Nephrolithiasis Stress urinary incontinence Inflammation Silodosin Hormonal therapy Tumor markers TMPRSS2ERG 4-Kallikrein panel Botulinum toxin type A Male voiding dysfunction Benign prostatic specific antigen Roux-en-Y gastric bypass surgery Genitourinary pain index UPOINT clinical phenotype system Nephron-sparing surgery Watchful waiting Laparoscopy for adrenal cortical carcinoma Partial adrenalectomy Urethral trauma Pediatric urethral stricture Enteric urologic surgery

Volume 12, Number 4 Review Articles

Metabolic Syndrome and Urologic Diseases

Mangement Review

Haluk Akpinar Ilya Gorbachinsky

Metabolic syndrome (MetS) is a complex entity consisting of multiple interrelated factors including insulin resistance, central adiposity, dyslipidemia, endothelial dysfunction and atherosclerotic disease, low-grade inflammation, and in males, low testosterone levels. MetS has been linked to a number of urologic diseases including nephrolithiasis, benign prostatic hyperplasia and lower urinary tract symptoms, erectile dysfunction, male infertility, female incontinence, and prostate cancer. This article reviews the relationships between MetS and these entities. Urologists need to be cognizant of the impact that MetS has on urologic diseases as well as on overall patient health.[Rev Urol. 2010;12(4):e157-e180 doi: 10.3909/riu0487]© 2010 MedReviews®, LLC

Obesity Metabolic syndrome Benign prostatic hyperplasia Nephrolithiasis Hypogonadism Cardiovascular disease Insulin resistance Endothelial dysfunction

Volume 17, Number 3 Review Articles

The Obesity Epidemic and Its Impact on Urologic Care

Management Update

Neil Baum David Mobley

Although heart disease and cancer are the number one and two causes of death in the United States, respectively, obesity is gaining speed as a contributing cause to both of those conditions, along with diabetes, arthritis, dyslipidemia, coronary heart disease, gallbladder disease, and certain malignancies. Nearly one-third of the adults in the United States is overweight with a body mass index (BMI) greater than 25 kg/m2, and another third of the adult population is obese, with a BMI greater than 30 kg/m2. This article reviews the root causes of obesity, the societal implications, and the implications of obesity on various urologic diseases. [Rev Urol. 2015;17(3):165-170 doi: 10.3909/riu0683] © 2015 MedReviews®, LLC

Obesity Morbid obesity Body mass index Exercise Weight loss Diet Epidemic

Volume 21, Number 4 Review Articles

Impact of Demographic Factors and Systemic Disease on Urinary Stone Risk Parameters Amongst Stone Formers

Original Research

Kyle Wood William Poore Barbara Gower Carter Boyd Dustin Whitaker Omotola Ashorobi Robert Oster Dean G Assimos

This article examines via multivariate analysis the associations between demographic factors and systemic diseases on stone risk parameters in a stone-forming population. A retrospective chart review of adult stone formers who completed 24-hour urine collections from April 2004 through August 2015 was performed. Data was collected on age, sex, race, body mass index (BMI), and diagnoses of diabetes and hypertension. CT imaging and renal/abdominal ultrasonography (within ±6 mo) were reviewed for diagnosis of fatty liver disease. Statistical analysis included Pearson and Spearman correlation analysis, and linear and logistic regression analyses, both univariate and multivariate. Five hundred eighty-nine patients were included. Numerous urinary parameters were significant in association with demographic factors or systemic diseases in a multivariate analysis. Older age was associated with decreased calcium (Ca) excretion (P = 0.0214), supersaturation of calcium oxalate (SSCaOx; P = 0.0262), supersaturation of calcium phosphate (SSCaP; P < 0.0001), and urinary pH (P = 0.0201). Men excreted more Ca (P = 0.0015) and oxalate (Ox; P = 0.0010), had lower urine pH (P = 0.0269), and higher supersaturation of uric acid (SSUA; P < 0.0001) than women. Blacks had lower urine volume (P = 0.0023), less Ca excretion (P = 0.0142), less Ox excretion (P = 0.0074), and higher SSUA (P = 0.0049). Diabetes was associated with more Ox excretion (P < 0.0001), lower SSCaP (P = 0.0068), and lower urinary pH (P = 0.0153). There were positive correlations between BMI and Ca excretion (P = 0.0386), BMI and Ox excretion (P = 0.0177), and BMI and SSUA (P = 0.0045). These results demonstrate that demographic factors and systemic disease are independently associated with numerous risk factors for kidney stones. The mechanisms responsible for these associations and disparities (racial differences) need to be further elucidated. [Rev Urol. 2019;21(4):158–165] © 2020 MedReviews®, LLC

Obesity Kidney stones Diabetes Systemic disease Fatty Liver